Durable remission after rechallenge with ipilimumab and nivolumab in metastatic Merkel cell carcinoma refractory to avelumab: Any role for sequential immunotherapy?

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)e80-e81
JournalJournal of Dermatology
Volume48
Issue number2
DOIs
StatePublished - Feb 2021

Cite this